Sanofi has finalized its takeover of Vigil Neuroscience for roughly $470 million, acquiring all outstanding shares at $8 each and issuing a $2-pe ...

Almirall and Absci have expanded their AI-based drug discovery collaboration by selecting a second dermatological target, following the initial s ...